ATE458476T1 - Verfahren für die zubereitung der amorphen form eines medikamentes - Google Patents
Verfahren für die zubereitung der amorphen form eines medikamentesInfo
- Publication number
- ATE458476T1 ATE458476T1 AT05758626T AT05758626T ATE458476T1 AT E458476 T1 ATE458476 T1 AT E458476T1 AT 05758626 T AT05758626 T AT 05758626T AT 05758626 T AT05758626 T AT 05758626T AT E458476 T1 ATE458476 T1 AT E458476T1
- Authority
- AT
- Austria
- Prior art keywords
- medication
- preparing
- amorphic form
- amorphic
- preparation
- Prior art date
Links
- 229940079593 drug Drugs 0.000 title 1
- 239000003814 drug Substances 0.000 title 1
- 239000008186 active pharmaceutical agent Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/18—Halogen atoms or nitro radicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
- C07D407/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
- C07D407/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- F—MECHANICAL ENGINEERING; LIGHTING; HEATING; WEAPONS; BLASTING
- F26—DRYING
- F26B—DRYING SOLID MATERIALS OR OBJECTS BY REMOVING LIQUID THEREFROM
- F26B11/00—Machines or apparatus for drying solid materials or objects with movement which is non-progressive
- F26B11/12—Machines or apparatus for drying solid materials or objects with movement which is non-progressive in stationary drums or other mainly-closed receptacles with moving stirring devices
-
- F—MECHANICAL ENGINEERING; LIGHTING; HEATING; WEAPONS; BLASTING
- F26—DRYING
- F26B—DRYING SOLID MATERIALS OR OBJECTS BY REMOVING LIQUID THEREFROM
- F26B5/00—Drying solid materials or objects by processes not involving the application of heat
- F26B5/04—Drying solid materials or objects by processes not involving the application of heat by evaporation or sublimation of moisture under reduced pressure, e.g. in a vacuum
- F26B5/041—Drying solid materials or objects by processes not involving the application of heat by evaporation or sublimation of moisture under reduced pressure, e.g. in a vacuum for drying flowable materials, e.g. suspensions, bulk goods, in a continuous operation, e.g. with locks or other air tight arrangements for charging/discharging
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Mechanical Engineering (AREA)
- General Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Medicinal Preparation (AREA)
- Steroid Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US57621604P | 2004-06-01 | 2004-06-01 | |
| US58377804P | 2004-06-28 | 2004-06-28 | |
| US59970004P | 2004-08-05 | 2004-08-05 | |
| PCT/US2005/019485 WO2005117837A1 (en) | 2004-06-01 | 2005-06-01 | Process for preparation of amorphous form of a drug |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE458476T1 true ATE458476T1 (de) | 2010-03-15 |
Family
ID=35134738
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT05758626T ATE458476T1 (de) | 2004-06-01 | 2005-06-01 | Verfahren für die zubereitung der amorphen form eines medikamentes |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US7589128B2 (de) |
| JP (1) | JP2008500405A (de) |
| KR (1) | KR20060123772A (de) |
| AT (1) | ATE458476T1 (de) |
| CA (1) | CA2560984A1 (de) |
| DE (1) | DE602005019509D1 (de) |
| DK (1) | DK1641438T3 (de) |
| ES (1) | ES2339682T3 (de) |
| IL (1) | IL179719A0 (de) |
| MX (1) | MXPA06010084A (de) |
| WO (1) | WO2005117837A1 (de) |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20060083784A1 (en) * | 2002-08-07 | 2006-04-20 | Smithkline Beecham Corporation | Amorphous pharmaceutical compositions |
| KR20070061583A (ko) | 2004-10-15 | 2007-06-13 | 테바 파마슈티컬 인더스트리즈 리미티드 | 텔미사르탄의 제조 방법 |
| EP1807400A2 (de) * | 2004-11-03 | 2007-07-18 | Teva Pharmaceutical Industries, Inc. | Amorphe und polymorphe formen von telmisartan-natrium |
| JP2007519758A (ja) | 2004-12-01 | 2007-07-19 | テバ ジョジセルジャール ザ−トケルエン ムケド レ−スベニュタ−ルシャシャ−グ | 結晶マクロライドの生成方法 |
| PT1855652E (pt) | 2005-01-28 | 2016-01-26 | Bend Res Inc | Secagem de partículas contendo fármacos |
| JP2008510840A (ja) | 2005-07-05 | 2008-04-10 | テバ ファーマシューティカル インダストリーズ リミティド | モンテルカストの精製 |
| WO2007059325A2 (en) * | 2005-11-16 | 2007-05-24 | Teva Pharmaceutical Industries Ltd. | Drying methods of montelukast sodium by azeotropic removal of the solvent |
| GB0613925D0 (en) | 2006-07-13 | 2006-08-23 | Unilever Plc | Improvements relating to nanodispersions |
| WO2008012617A1 (en) | 2006-07-21 | 2008-01-31 | Pfizer Products Inc. | Drying of drug-containing particles |
| GB2441328A (en) * | 2006-08-30 | 2008-03-05 | Alpharma Aps | A method for obtaining mupirocin calcium |
| US20080187684A1 (en) * | 2007-02-07 | 2008-08-07 | Imra America, Inc. | Method for depositing crystalline titania nanoparticles and films |
| TW200936582A (en) * | 2007-11-26 | 2009-09-01 | Teva Pharma | Amorphous retapamulin and processes for preparation thereof |
| GB2457452B (en) * | 2008-02-12 | 2010-05-12 | Pliva Lachema As | Amorphous form of (OC-6-43)-bis(acetate)(1-tricyclo[3,3,1,13,7]decylamine) amminedichloroplatinum (IV) |
| EP2366378A1 (de) | 2010-03-01 | 2011-09-21 | Dexcel Pharma Technologies Ltd. | Donepezilformulierungen mit verzögerter Freisetzung |
| WO2011121596A2 (en) * | 2010-04-01 | 2011-10-06 | Neuland Laboratories Ltd. | Crystal modification of moxifloxacin hydrochloride |
| US8471030B2 (en) | 2010-12-06 | 2013-06-25 | Orochem Technologies Inc. | Purification of montelukast using simulated moving bed |
| AU2019334202A1 (en) | 2018-09-06 | 2021-03-25 | Innopharmascreen, Inc. | Methods and compositions for treatment of asthma or parkinson's disease |
| WO2025146702A1 (en) * | 2024-01-03 | 2025-07-10 | Msn Laboratories Private Limited, R&D Center | Solid state forms of 1-{(2s,5r)-2-methyl-5-[(7h-pyrrolo[2,3-d]pyrimidin-4-yl)amino] piperidine-1-yl}prop-2-en-1-one 4-methylbenzene-1-sulfonic acid |
Family Cites Families (34)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE1643240A1 (de) | 1966-09-16 | 1971-06-24 | Boehringer Sohn Ingelheim | Verfahren zur Herstellung neuer racemischer oder optisch aktiver 1-Phenoxy-2-aminoalkane |
| GB1395907A (en) | 1971-06-12 | 1975-05-29 | Beecham Group Ltd | Antibiotics |
| US3977943A (en) | 1971-06-12 | 1976-08-31 | Beecham Group Limited | Antibiotics |
| US4071536A (en) | 1971-06-12 | 1978-01-31 | Beecham Group Limited | Antibiotics |
| JPS5270083A (en) | 1975-12-04 | 1977-06-10 | Yoshitomi Pharmaceut Ind Ltd | Manufacture of an antibiotics, trans-pseudomonic acid |
| GB1577730A (en) | 1976-10-23 | 1980-10-29 | Beecham Group Ltd | Treatment of infections with pseudomonicacid salts or esters thereof |
| GB1577545A (en) | 1977-07-27 | 1980-10-22 | Beecham Group Ltd | Treatment of swine dysenter |
| CA1103264A (en) | 1977-09-30 | 1981-06-16 | Norman H. Rogers | Purification of pseudomonic acid |
| CA1115699A (en) | 1978-05-20 | 1982-01-05 | Alan D. Curzons | Lithium pseudomonate and its preparation |
| CA1196284A (en) | 1982-05-28 | 1985-11-05 | Joshua Oduro-Yeboah | Pharmaceutical formulations |
| GB8415579D0 (en) | 1984-06-19 | 1984-07-25 | Beecham Group Plc | Compounds |
| GB8428952D0 (en) | 1984-11-16 | 1984-12-27 | Beecham Group Plc | Formulations |
| GB8530796D0 (en) | 1985-12-13 | 1986-01-22 | Beecham Group Plc | Pharmaceutical composition |
| IE59628B1 (en) | 1986-06-26 | 1994-03-09 | Beecham Group Plc | Treatment of fungal infections |
| US5594026A (en) | 1990-12-11 | 1997-01-14 | Smithkline Beecham Group P.L.C. | Polymorphs of crystalline mupirocin |
| US5292892A (en) | 1991-05-07 | 1994-03-08 | Sankyo Company, Limited | Anti-bacterial compound and pharmaceutical compositions thereof |
| US6503881B2 (en) | 1996-08-21 | 2003-01-07 | Micrologix Biotech Inc. | Compositions and methods for treating infections using cationic peptides alone or in combination with antibiotics |
| PL332642A1 (en) | 1996-10-01 | 1999-09-27 | Smithkline Beecham Corp | Application of mupyrrocin in production of a drug for treating bacterial infections associated with invasion of nasopharynx by pathogenic organisms |
| EP1032647B1 (de) * | 1997-11-26 | 2006-03-29 | Universal Preservation Technologies, Inc. | Konservierung empfindlicher biologischer proben durch verglasung |
| US6231875B1 (en) | 1998-03-31 | 2001-05-15 | Johnson & Johnson Consumer Companies, Inc. | Acidified composition for topical treatment of nail and skin conditions |
| US6306345B1 (en) | 1998-05-06 | 2001-10-23 | Universal Preservation Technologies, Inc. | Industrial scale barrier technology for preservation of sensitive biological materials at ambient temperatures |
| KR20010112258A (ko) | 1999-02-03 | 2001-12-20 | 자노스 바르가, 테레지아 밀레 | 슈도몬산 복합물을 함유하는 배양 브로쓰로부터 슈도몬산a를 분리하는 방법 |
| MXPA01007806A (es) | 1999-02-03 | 2003-06-04 | Biogal Gyogyszergyar | Proceso para la preparacion del antibiotico acido pseudomonico a mediante un metodo microbiologico. |
| IN191492B (de) | 1999-05-25 | 2003-12-06 | Ranbaxy Lab Ltd | |
| US6335023B1 (en) | 1999-06-30 | 2002-01-01 | Ruey J. Yu | Oligosaccharide aldonic acids and their topical use |
| US6528086B2 (en) | 1999-09-28 | 2003-03-04 | Zars, Inc. | Methods and apparatus for drug delivery involving phase changing formulations |
| IL137363A (en) | 2000-07-18 | 2005-12-18 | Agis Ind 1983 Ltd | Pharmaceutical compositions containing mupirocin |
| WO2003000910A2 (en) | 2001-06-21 | 2003-01-03 | Biogal Gyogyszergyar Rt | Metabolic controlled fermentation process for pseudomonic acid production |
| EP1404792B1 (de) | 2001-07-11 | 2009-08-26 | The Procter and Gamble Company | Verfahren zur oberflächenreinigung mittels eines dispergierten polymers |
| US7737177B2 (en) | 2001-12-28 | 2010-06-15 | TEVA Gyógyszergyár Zártkörüen Müködö Részvénytárasaság | Processes for preparing crystalline and amorphous mupirocin calcium |
| RU2278659C9 (ru) | 2002-02-01 | 2007-02-20 | Пфайзер Продактс Инк. | Способ получения гомогенных, высушенных распылением твердых аморфных дисперсий лекарственного средства с использованием модифицированной установки сушки распылением |
| WO2003063821A2 (en) | 2002-02-01 | 2003-08-07 | Pfizer Products Inc. | Method for making homogeneous spray-dried solid amorphous drug dispersions using pressure nozzles |
| IL150907A (en) | 2002-07-25 | 2007-07-04 | Stephan Cherkez | Process for the preparation of stable amorphous calcium pseudomonate |
| JP2007519758A (ja) | 2004-12-01 | 2007-07-19 | テバ ジョジセルジャール ザ−トケルエン ムケド レ−スベニュタ−ルシャシャ−グ | 結晶マクロライドの生成方法 |
-
2005
- 2005-06-01 US US11/143,312 patent/US7589128B2/en not_active Expired - Fee Related
- 2005-06-01 JP JP2007527596A patent/JP2008500405A/ja active Pending
- 2005-06-01 WO PCT/US2005/019485 patent/WO2005117837A1/en not_active Ceased
- 2005-06-01 KR KR1020067018664A patent/KR20060123772A/ko not_active Ceased
- 2005-06-01 DK DK05758626.5T patent/DK1641438T3/da active
- 2005-06-01 CA CA002560984A patent/CA2560984A1/en not_active Abandoned
- 2005-06-01 DE DE602005019509T patent/DE602005019509D1/de not_active Expired - Lifetime
- 2005-06-01 ES ES05758626T patent/ES2339682T3/es not_active Expired - Lifetime
- 2005-06-01 AT AT05758626T patent/ATE458476T1/de not_active IP Right Cessation
- 2005-06-01 MX MXPA06010084A patent/MXPA06010084A/es unknown
-
2006
- 2006-11-30 IL IL179719A patent/IL179719A0/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| US20050272768A1 (en) | 2005-12-08 |
| IL179719A0 (en) | 2007-05-15 |
| US7589128B2 (en) | 2009-09-15 |
| KR20060123772A (ko) | 2006-12-04 |
| DK1641438T3 (da) | 2010-06-07 |
| ES2339682T3 (es) | 2010-05-24 |
| WO2005117837A1 (en) | 2005-12-15 |
| DE602005019509D1 (de) | 2010-04-08 |
| MXPA06010084A (es) | 2007-03-01 |
| JP2008500405A (ja) | 2008-01-10 |
| CA2560984A1 (en) | 2005-12-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE458476T1 (de) | Verfahren für die zubereitung der amorphen form eines medikamentes | |
| GEP20105082B (en) | (biphenyl) carboxylic acids and derivatives thereof | |
| GEP20125425B (en) | Biaryl ether urea compounds | |
| IL193951A (en) | A compound with central pyrrolidine units, an intermediate compound for the preparation of the mediated compound, a process for the production of the mediated compound, the use of a mediated compound for the manufacture of a drug, a pharmaceutical preparation, a method for the preparation of a pharmaceutical preparation, and a method for making conventional pharmaceutical salt of a non-salts compound. | |
| ATE556074T1 (de) | Neue imidazoä1,5-aüpyridinderivate, verfahren zu deren herstellung und pharmazeutische zusammensetzungen, die diese enthalten | |
| GEP20135919B (en) | Benzoic acid (1-phenyl-2-pyridin-4-yl) ethyl esters as phosphodiesterase inhibitors | |
| ATE522529T1 (de) | Verfahren zur herstellung von pyridoä2,1- aüisochinolinderivaten, das die racematspaltung eines enamins umfasst | |
| TW200833682A (en) | Pharmaceutical compounds | |
| EA200600621A1 (ru) | Производные тетрагидронафталина, способ их получения и их применение в качестве противовоспалительных средств | |
| NO20075557L (no) | Krystaller av morfinanderivat og fremgangsmate for fremstilling derav | |
| NZ600786A (en) | Proteasome inhibitors and processes for their preparation, purification and use | |
| ATE444950T1 (de) | Verfahren zur herstellung von 1-amino-3,5- dimethyladamantan-hydrochlorid | |
| MX2021011823A (es) | Derivado pirroloheterociclico, metodo de preparacion del mismo y su aplicacion en medicina. | |
| DK1594885T3 (da) | Lægemiddel til vækstinhibering af tumorer | |
| EA200801893A1 (ru) | Производные тетрагидронафталина, способ их получения и их применение в качестве ингибиторов воспаления | |
| ATE536864T1 (de) | Metoprololsuccinat tabletten mit verlängerter freisetzung und verfahren für deren herstellung | |
| ATE500226T1 (de) | Aripiprazolhemifumarat und verfahren zu dessen herstellung | |
| ATE441630T1 (de) | Substituierte cyclopenten-verbindungen | |
| NO20091334L (no) | Fremgangsmate for syntese av klopidogrel og nye former for farmasoytisk akseptable salter derav | |
| SE0401655D0 (sv) | New compounds | |
| PH12022550254A1 (en) | MICROMOLECULE PI4KIIIa INHIBITOR COMPOSITION, PREPARATION METHOD THEREFOR AND USE THEREOF | |
| ATE374172T1 (de) | Hexensäurederivate, verfahren zu deren herstellung, pharmazeutische zusammensetzungen, die diese enthalten, und therapeutische anwendungen davon | |
| DE502006008551D1 (de) | Verfahren zur herstellung eines hydroxystilben-haltigen drogenextraktes | |
| ATE344259T1 (de) | Verfahren und zwischenprodukte für die herstellung von emtricitabin | |
| EP4429611A4 (de) | Verfahren zur verabreichung eines arzneimittels an die netzhaut |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |